Eliot Marshall
Richard Klausner, the new director of the National Cancer Institute, has championed a project to use yeast cells bearing human cancer genes to screen for anti-cancer drugs. The project has won widespread praise from researchers, but Klausner has raised some eyebrows by using an unconventional mechanism to fund it: It will be an outpost of NIH's intramural program, based in Seattle.